Form 4: Acelyrin Director Bruce C. Cozadd Acquires 92,158 Stock Options

Director Bruce C. Cozadd reports acquisition of 92,158 stock options in Acelyrin, Inc.

Summary

• Bruce C. Cozadd, a director of Acelyrin, Inc. (SLRN), reported the acquisition of 92,158 stock options on June 7, 2024.
• The options have an exercise price of $4.46.
• The options vest on the earlier of June 7, 2025, or the day before the next annual meeting of stockholders, contingent upon continued service as a director.
• The expiration date for the options is June 6, 2034.
• Following the transaction, Cozadd directly owns 92,158 derivative securities.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a standard disclosure of stock option acquisition by a director, which can be interpreted as a sign of confidence, but doesn't provide enough information to strongly skew positive or negative.

Positives

• A director's acquisition of stock options can be seen as a positive sign, indicating confidence in the company's future performance.

Industry Context

Form 4 filings are standard disclosures required by the SEC to provide transparency into the transactions of company insiders. This filing indicates changes in beneficial ownership of Acelyrin's securities by a director.

Stakeholder Impact

• Shareholders may view the acquisition of stock options by a director as a positive signal, aligning management's interests with theirs.

Key Dates